Serious hypersensitivity reactions, including anaphylaxis and angioedema have been reported with Wegovy LIMITATIONS OF USE According to the package insert, Wegovy should not be coadministered with other semaglutide-containing products or with any GLP-1 receptor agonist safety and efficacy in combination with other products intended for weight loss, including prescription drugs, over-the-counter drugs, and herbal preparations, have not been established has not been studied in patient with a history of pancreatitis WARNINGS AND PRECAUTIONS The safety profile of semaglutide in the treatment of obesity has been investigated through several clinical trials
Common side effects of semaglutide The common side effects of semaglutide injections include: Gastrointestinal issues: Gastrointestinal problems like nausea, vomiting, constipation, and diarrhea are the most common side effects of semaglutide
GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
, , 1
Open communication with your doctor is the key to achieving your personal health goals
A group of 338 participants were split into two test groups